MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Early Phase 1

Completed

Conditions: Recurrent Mantle Cell Lymphoma
Refractory Mantle Cell Lymphoma
Recurrent Grade 3 Follicular Lymphoma
Transformed Recurrent Non-Hodgkin Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma

Interventions: Drug: Buparlisib
Other: Laboratory Biomarker Analysis
Other: Questionnaire Administration

First Posted Date: 2012-11-01

Last Posted Date: 2018-10-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 7

Registration Number: NCT01719250

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Cortical Excitability and Inhibition in MDD

Completed

Conditions: Major Depressive Disorder, Recurrent, Mild
Depressive Disorder, Major

Interventions: Device: Transcranial Magnetic Stimulation (TMS)
Device: Magnetic Resonance Spectroscopy and Imaging

First Posted Date: 2012-10-31

Last Posted Date: 2019-10-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 23

Registration Number: NCT01718730

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C)

Phase 1

Completed

Conditions: IBS

Interventions: Drug: Mexiletine

First Posted Date: 2012-10-30

Last Posted Date: 2013-10-01

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT01717404

Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer

Phase 2

Terminated

Conditions: Carcinoma, Non-Small-Cell Lung
Lung Neoplasms

Interventions: Other: Placebo Comparator
Drug: Metformin

First Posted Date: 2012-10-30

Last Posted Date: 2020-03-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 6

Registration Number: NCT01717482

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Sleep Apnea and Vascular Function

Not Applicable

Completed

Conditions: OSA

Interventions: Other: Sleep Study

First Posted Date: 2012-10-30

Last Posted Date: 2017-11-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 45

Registration Number: NCT01717339

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

A Pilot Study to Evaluate the Contribution of the Saphenous Nerve in Ankle Pain of Patients With Degenerative Joint Disease of the Ankle

Terminated

Conditions: Degenerative Joint Disease of the Ankle

First Posted Date: 2012-10-30

Last Posted Date: 2019-04-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 4

Registration Number: NCT01716650

Locations: 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States

Safety Study of Inhaled Saline in Acute Lung Injury

Phase 1

Withdrawn

Conditions: Pulmonary Edema

Interventions: Drug: Hypertonic Saline Aerosol

First Posted Date: 2012-10-25

Last Posted Date: 2015-08-17

Lead Sponsor: Mayo Clinic

Registration Number: NCT01713595

Does Tranexamic Acid Reduce the Need for Blood Transfusions in Patients Undergoing Hip Fracture Surgery?

Phase 4

Completed

Conditions: Hip Fracture

Interventions: Drug: placebo
Drug: tranexamic acid

First Posted Date: 2012-10-25

Last Posted Date: 2018-11-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 138

Registration Number: NCT01714336

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Feasibility of Use of BariCare App in Pre-bariatric Surgery.

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Use of smartphone app

First Posted Date: 2012-10-16

Last Posted Date: 2014-09-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT01708135

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant

Phase 2

Completed

Conditions: Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions: Drug: bortezomib
Drug: lenalidomide
Other: laboratory biomarker analysis
Drug: cyclophosphamide
Procedure: quality-of-life assessment
Drug: dexamethasone

First Posted Date: 2012-10-15

Last Posted Date: 2018-09-17

Lead Sponsor: Mayo Clinic

Target Recruit Count: 3

Registration Number: NCT01706666

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Baylor Medical Center, Garland, Texas, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy